1Y Annualised Return
▼-25.18%
3Y Annualised Return
▼-3.94%
Zim Laboratories Stock Performance
|
|
|
Zim Laboratories Company background
Founded in: 1984
Managing director: Anwar S Daud
Zim Laboratories Limited was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in Maharashtra. The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Mumbai. The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India. The Pharma Industry is dominated by Multinationals, Large Indian companies and in the lower end of the market large number of units mainly in the SSI sector.During the year 201920, ZIM Health Technologies Limited was acquired, making it a wholly owned subsidiary of the Company. SIA ZIM Laboratories Limited got incorporated as a wholly owned subsidiary in Latvia.In 2023, the Company launched Thinoral (Patented Oral Thin Film technology) as an alternate drug delivery platform across RoW/Pharmerging Markets and EU. The Company entered into a joint venture with an Australian marketing company to launch New Innovative Products (NIP) and Oral Thin Films (OTF) in 2025. The OTF business marked a milestone with its first commercial order supplied in Europe for Sildenafil citrate 50 milligram ODS. The product was launched in Italy and Malta in 2025.
Zim Laboratories Financial Highlights
For the full year FY2025–2026, revenue
reached ₹384.82 crore and profit touched at
₹12.16 crore.
Zim Laboratories Share Price Today
As of 21 Jan 2026, Zim Laboratories share price is ₹71. The stock opened at ₹75 and had closed at ₹76.1 the previous day. During today’s trading session, Zim Laboratories share price moved between ₹69.75 and ₹76.22, with an average price for the day of ₹72.98. Over the last 52 weeks, the stock has recorded a low of ₹65.52 and a high of ₹127.00. In terms of performance, Zim Laboratories share price has declined by 40.3% over the past six months and has declined by 25.18% over the last year.
Zim Laboratories SIP Return Calculator
₹5,000
Over the past
Total Investment of ₹0
Monthly SIP of ₹5,000 would have become ₹0 in 3 years with a gain of ₹0 (+0.00%)
Zim Laboratories Fundamental
Market Cap (in crs)
371.46
Face Value
10
Turnover (in lacs)
54.15
Key Metrics
Qtr Change %
44.07% Fall from 52W High
4.7
Dividend yield 1yr %
0
Zim Laboratories Key Financials
View moreLoading chart...
Zim Laboratories Quarterly Revenue
88.71 Cr | 71.76 Cr | 108.73 Cr | 96.33 Cr | 92.14 Cr |
Zim Laboratories Yearly Revenue
384.82 Cr | 372.61 Cr | 404.94 Cr | 337.83 Cr | 309.6 Cr | 282.26 Cr |
Zim Laboratories Quarterly Net Profit/Loss
-0.42 Cr | -1.87 Cr | 4.88 Cr | 4 Cr | 2.38 Cr |
Zim Laboratories Yearly Net Profit/Loss
12.16 Cr | 17.25 Cr | 24.43 Cr | 14.55 Cr | 7.32 Cr | 3.3 Cr |
Zim Laboratories Result Highlights
Result Summary
-
Zim Laboratories Ltd reported a 23.9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 2.9%.
-
Its expenses for the quarter were up by 20.4% QoQ and 0.7% YoY.
-
The net profit decreased 77.5% QoQ and decreased 117.6% YoY.
-
The earnings per share (EPS) of Zim Laboratories Ltd declined at 0.09 during Q2 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Zim Laboratories Technical Analysis
Moving Averages Analysis
70.55
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
Day EMA5
76.20
Day EMA10
74.60
Day EMA12
74.10
Day EMA20
73.10
Day EMA26
72.80
Day EMA50
72.80
Day EMA100
75.60
Day EMA200
82.20
Delivery & Volume
Loading chart...
Delivery Volume %
Day
78.50%
Week
70.10%
Month
68.80%
Delivery & Volume
Day Rs | 83147 Rs | 105919 Rs |
Week Rs | 84386 Rs | 120316 Rs |
Month Rs | 53605 Rs | 77942 Rs |
Resistance & Support
77.02
Pivot
Resistance
First Resistance
78.38
Second Resistance
80.67
Third Resistance
82.03
Support
First Support
74.73
Second support
73.37
Third Support
71.08
Relative Strength Index
58.40
Money Flow Index
69.99
MACD
1.37
MACD Signal
0.42
Average True Range
3.24
Average Directional Index
19.32
Rate of Change (21)
6.96
Rate of Change (125)
-36
Zim Laboratories Peer comparison
Compare404.00 -11.25 (-2.71%)▼ | |
279.80 -1.95 (-0.69%)▼ | |
13.03 -0.03 (-0.23%)▼ | |
1,234.60 -18.10 (-1.44%)▼ | |
70.55 -5.67 (-7.44%)▼ | |
288.35 -16.65 (-5.46%)▼ |
Zim Laboratories Latest News
Zim Laboratories Share Price FAQs
Please be aware that Zim Laboratories stock prices are subject to continuous fluctuations due to various factors.
Invest in Zim Laboratories
Popular Stocks | |||||||||
45.53 -0.81 (-1.75%)▼ | |||||||||
115.14 -0.99 (-0.85%)▼ | |||||||||
339.25 +1.40 (+0.41%)▲ | |||||||||
2,032.20 -22.90 (-1.11%)▼ | |||||||||
127.38 -2.56 (-1.97%)▼ | |||||||||
317.10 -3.20 (-1.00%)▼ | |||||||||
184.41 +0.85 (+0.46%)▲ | |||||||||
283.50 +13.90 (+5.16%)▲ | |||||||||
402.65 -6.70 (-1.64%)▼ | |||||||||
349.35 -3.60 (-1.02%)▼ | |||||||||
Top Gainers | |||||||||
283.50 +13.90 (+5.16%)▲ | |||||||||
12,231.00 +172.00 (+1.43%)▲ | |||||||||
4,857.50 +67.50 (+1.41%)▲ | |||||||||
1,174.60 +14.60 (+1.26%)▲ | |||||||||
939.20 +11.10 (+1.20%)▲ | |||||||||
Top Losers | |||||||||
1,349.00 -26.80 (-1.95%)▼ | |||||||||
3,764.40 -71.70 (-1.87%)▼ | |||||||||
1,163.60 -21.40 (-1.81%)▼ | |||||||||
402.65 -6.70 (-1.64%)▼ | |||||||||
6,826.50 -86.00 (-1.24%)▼ | |||||||||
Open Demat Account